Similarly, an observational study of 43 patients to evaluate the treatment responsiveness of patients with KCNT1-related epilepsy reported that quinidine was not utilized in any patients with an ADNFLE phenotype, whereas quinidine treatment was attempted in 17 patients with an EIMFS phenotype. Here, KCNT1 is linked to epilepsy.